These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2439577)

  • 21. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C; Rougier P; Bizollon T; Poupon R; Zarski JP; Quinton A; Miguet JP; Causse X; Chossegros P; Chevallier M
    J Hepatol; 1991; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.
    Trépo C; Ouzan D; Fontanges T; Chevallier M; Chossegros P; Degos F; Chevallier P; Hantz O
    J Hepatol; 1986; 3 Suppl 2():S97-105. PubMed ID: 2439581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
    Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC
    J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M; Uchiumi K
    J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials.
    Müller R; Klein H; Vido I; Niehoff G; Lautz HU; Gebel M; Schmidt FW
    J Hepatol; 1986; 3 Suppl 2():S217-23. PubMed ID: 2439573
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trial.
    Guarascio P; De Felici AP; Migliorini D; Alexander GJ; Fagan EA; Visco G
    J Hepatol; 1986; 3 Suppl 2():S143-7. PubMed ID: 3298405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.
    Amini-Bavil-Olyaee S; Herbers U; Sheldon J; Luedde T; Trautwein C; Tacke F
    Hepatology; 2009 Apr; 49(4):1158-65. PubMed ID: 19263474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B.
    Nair PV; Tong MJ; Stevenson D; Roskamp D; Boone C
    Hepatology; 1986; 6(6):1319-24. PubMed ID: 2431991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.
    Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M
    Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term corticosteroid therapy for chronic active hepatitis B.
    Laskus T; Cianciara J; Loch T; Slusarczyk J
    Digestion; 1990; 47(2):115-20. PubMed ID: 2292353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
    Lee SU; Choi KH; Ha BJ; Suh SY; Han BH; Ku JY; Park BC
    Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
    Lee SD; Tong MJ; Wu JC; Lin HC; Tsai YT; Lo KJ
    J Hepatol; 1991 Mar; 12(2):246-50. PubMed ID: 2051004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.
    Wood JR; Czaja AJ; Taswell HF; Ludwig J; Rakela J; Chase R
    Gastroenterology; 1987 Dec; 93(6):1225-30. PubMed ID: 3678739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of serum hepatitis B virus deoxyribonucleic acid in hepatitis B surface antigen-positive patients with chronic persistent hepatitis treated with prednisone.
    Tong MJ; Liu S; Co RL
    Gastroenterology; 1987 Apr; 92(4):862-6. PubMed ID: 3556993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term results of treatment of chronic active hepatitis B with vidarabine monophosphate].
    Causse X; Guérou V; Rougier P; Trépo C
    Gastroenterol Clin Biol; 1993; 17(2):144-5. PubMed ID: 7684714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.